跳至主要内容
临床试验/DRKS00011344
DRKS00011344已完成不适用

Identifikation of parameters for the development of a Score to predict the non-compliance of patients with recurrent ovarian cancer undergoing a routine therapy with Ovastat(R).A non-interventional observation trial (NIS) - SCORE trial

medac Gesellschaft für klinische Spezialpräparate mbH0 个研究点目标入组 194 人开始时间: 2016年11月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
194

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
Female

入选标准

  • patients with recurrent ovarian cancer who have decided to undergo a chemotherapy with treosulfan
  • - patients aged 18 years or older
  • - patients who are able to answer questionaires in german language
  • - willingness to answer questionaires
  • - before entering the trial informed consent and data privacy statement must be signed by the patient

排除标准

  • contemporaneous partizipation in a different clinical trial during the time of treatment or within the last 30 days.
  • - hypersensitivity to treosulfan
  • - patients with missing or reduced legal competence
  • - patients in an instituion due to a legal or governmental order
  • - pregnant and breast-feeding women
  • - no anamnesis form (contains only data collected in routine anamnesis)

研究者

相似试验